spacer
home > ebr > summer 2017 > complex characters
PUBLICATIONS
European Biopharmaceutical Review

Complex Characters

Oligonucleotides are biopolymers consisting of modified ribonucleotide or deoxynucleotide monomer units. Since they play such a critical role at the human cellular level, they are being developed by several biopharmaceutical organisations as potential therapies and vaccines and are considered to be their own unique modality, distinct from traditional small molecule drugs and biologics.

The FDA has approved a number of these biopolymers, including fomivirsen, pegaptanib and mipomersen, primarily antisense oligonucleotides (ASOs), with several more on the way. In Europe, the Committee for Medicinal Products for Human Use, a division of the EMA, has recently recommended nusinersen for approval. n 100 oligonucleotide drugs progressing through the development pipeline, designed to target diseases and rare genetic disorders, including Huntington’s disease, asthma and certain types of cancer, as well as vaccines for the Ebola, Zika and influenza viruses.

Brief Background

Messenger RNA (mRNA) is a type of oligonucleotide that is critical to the translation of genetic sequence information of DNA into the specific amino acid array of proteins manufactured in the ribosomes of a cell’s cytoplasm. In eukaryote human cells, mRNA consists of several distinct regions. This naturally occurring sequence is known as the sense sequence.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jon S Kauffman, PhD, is Senior Director of Biopharmaceutical Services and Method Development and Validation at Eurofins Lancaster Laboratories. With more than 25 years of analytical testing experience, he oversees departments responsible for developing and validating methods and performing analysis of clinical and commercial samples for stability and release purposes. Jon earned a doctorate in chemistry from the University of Delaware, US.
spacer
Jon S Kauffman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Edinburgh, UK – September 20th, 2017 - Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
More info >>

White Papers

Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles

NanoSight

The study of exosomes and other cell-derived microvesicles is an area of rapidly growing importance and the subject of intense interest and research. The previous lack of suitable methods for their detection, analysis, enumeration and phenotyping is proving to be a significant limitation in these studies. This mini-review shows the degree to which the technique of Nanoparticle Tracking Analysis (NTA) is helping to address these problems.
More info >>

 
Industry Events

PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography

8-11 July 2018, Hyatt Regency in the Baltimore Inner Harbor, MD, USA

The PREP series of symposia is the most recognized international conference devoted to advances in separation technologies in the field of preparative and process chromatography. Join us for a dynamic and innovative program where experts from around the world will address the latest developments and hottest topics in preparative and process chromatography.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement